Cargando…
A five‐microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower‐grade glioma
Despite the prognostic value of IDH and other gene mutations found in diffuse glioma, markers that judge individual prognosis of patients with diffuse lower‐grade glioma (LGG) are still lacking. This study aims to develop an expression‐based microRNA signature to provide survival and radiotherapeuti...
Autores principales: | Zhang, Jian‐Hua, Hou, Ruiqin, Pan, Yuhualei, Gao, Yuhan, Yang, Ying, Tian, Wenqin, Zhu, Yan‐Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339211/ https://www.ncbi.nlm.nih.gov/pubmed/32412186 http://dx.doi.org/10.1111/jcmm.15377 |
Ejemplares similares
-
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
por: Zhang, Qiang, et al.
Publicado: (2021) -
Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma
por: Li, Guangqi, et al.
Publicado: (2020) -
RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas
por: Zhao, Xu, et al.
Publicado: (2022) -
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020) -
Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma
por: Liu, Zhizheng, et al.
Publicado: (2021)